Equine laminitis: membrane type matrix metalloproteinase-1 (MMP-14) is involved in acute phase onset.

Summary

Laminitis involves catastrophic failure of the lamellae at the dermal-epidermal interface, and this 2008 study investigated whether matrix metalloproteinases—enzymes capable of degrading the structural proteins holding these tissues together—might be the culprits driving acute phase onset. Kyaw-Tanner's team characterised the distribution and activity of MMP-14 (a membrane-bound collagenase) and its natural inhibitors (TIMPs) within lamellar tissue samples from horses during the prodromal and acute phases of laminitis, comparing affected tissue to healthy controls. They demonstrated significant upregulation of MMP-14 activity specifically during acute phase laminitis, localised to the basal epithelial cells of the dermal-epidermal junction where lamellae begin to separate. Understanding which MMPs drive lamellar breakdown and when they become active helps explain the enzymatic cascade underlying laminitis pathogenesis, potentially pointing toward future therapeutic interventions targeting these proteases or their regulators. For practitioners, this research underscores why early intervention during the prodromal phase—before acute enzymatic degradation is underway—may be critical for preserving lamellar integrity and preventing irreversible structural damage.

Read the full abstract on PubMed

Key Findings

• •Membrane type matrix metalloproteinase-1 (MMP-14) is involved in the onset of acute phase laminitis
• •Enzymatic separation occurs at the hoof lamellar dermal-epidermal interface during laminitis development
• •Characterization of MMPs and their tissue inhibitors (TIMPs) in lamellar tissues is relevant to understanding laminitis pathogenesis

Conditions Studied